Biologics discovery continues to evolve at a rapid pace, utilizing scientific breakthroughs and technological advancements to design and develop new and novel biological entities. Join us to learn about new capabilities in the recent release of Dotmatics Bioregister 3.0 to support these advances. New features include enhanced support for non-natural residues, improved relationship definition and tracking between entities, and API extensions to streamline discovery workflows.
Who should attend?
New customers: Scientists and managers engaged in biologics discovery who need a system to ensure both that their intellectual property is protected and that scientists can easily access this valuable information.
Existing Bioregister users: Learn about new and enhanced features, particularly if you are involved in non-natural peptide development, or if you just want to keep up with the latest in Bioregister!
- Andrew LeBeau, Senior Manager of Biologics Marketing
- Steve Manning, Application Science Team Leader